Sunday M L, Schuricht A L, Barbot D J, Rosato F E
Department of Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania.
Am Surg. 1994 Jan;60(1):63-7.
Percutaneous drainage of pancreatic collections has recently been advocated as a means of diagnosis of bacterial contamination, for temporizing unstable patients, and as definitive treatment in itself. In order to assess its efficacy, the role of percutaneous drainage of infected pancreatic fluid collections was retrospectively reviewed by a single surgical practice. Seventeen patients were treated over a 5-year period from 1987 to 1992. All patients admitted or referred with a diagnosis of infected peripancreatic fluid collection were included in the review. The group consisted of eleven males and six females; mean age was 55.2 years (range 28 to 70). Patients were stratified into one of two groups based on initial treatment modality. Group A consisted of eight patients treated initially with percutaneous drainage as presumed definitive management. Eight patients in Group B were treated initially with surgical debridement and drainage. APACHE II scores on admission were 5.62 +/- 3.66 for Group A and 9.12 +/- 3.87 for Group B (N.S.). Mean hospital stay was 100 days (range 13-311) for Group A and 71 (range 25-149) for Group B (N.S.). Despite initial percutaneous drainage, six of eight (75%) patients in Group A required operative debridement because of clinical deterioration. APACHE II scores in this subset went from 6.83 +/- 3.43 to 9.83 +/- 5.04 (N.S.) despite a total of 18 preoperative percutaneous procedures (2.25 per patient; range 1-7). The number of complications for this group totaled 15. Five of the six patients with positive cultures from their initial aspiration failed percutaneous drainage.(ABSTRACT TRUNCATED AT 250 WORDS)
经皮穿刺引流胰腺积液最近被提倡作为诊断细菌污染的一种手段,用于稳定病情不稳定的患者,以及作为一种确定性治疗方法。为了评估其疗效,一家外科诊所对感染性胰腺积液经皮穿刺引流的作用进行了回顾性研究。在1987年至1992年的5年期间,共治疗了17例患者。所有因诊断为感染性胰周积液而入院或转诊的患者均纳入本研究。该组包括11名男性和6名女性;平均年龄为55.2岁(范围28至70岁)。根据初始治疗方式,患者被分为两组之一。A组由8例最初接受经皮穿刺引流作为确定性治疗的患者组成。B组的8例患者最初接受手术清创和引流。A组入院时的急性生理与慢性健康状况评分系统(APACHE II)评分为5.62±3.66,B组为9.12±3.87(无统计学差异)。A组的平均住院时间为100天(范围13 - 311天),B组为71天(范围25 - 149天)(无统计学差异)。尽管最初进行了经皮穿刺引流,但A组8例患者中有6例(75%)因病情恶化需要手术清创。该亚组的APACHE II评分从6.83±3.43升至9.83±5.04(无统计学差异),尽管术前总共进行了18次经皮穿刺操作(每位患者2.25次;范围1 - 7次)。该组的并发症总数为15例。最初穿刺培养阳性的6例患者中有5例经皮穿刺引流失败。(摘要截选至250字)